Radical resection of a malignant soft tissue tumor in the shoulder region, where the tumor plus required margins measure 5 cm or greater.
Verified May 8, 2026 · 6 sources ↓
- Medicare
- $1,325.68
- Total RVUs
- 39.69
- Global, days
- 90
- Region
- Shoulder
Documentation requirements
What must appear in the operative or office note to support the claim.
Source · Editorial brief grounded in 6 cited references ↓
- Operative note must state tumor size and total resection dimensions including margins, confirming 5 cm or greater threshold is met
- Pathology report confirming malignant diagnosis (e.g., sarcoma or other malignant neoplasm) to support medical necessity
- Preoperative imaging (MRI preferred) documenting tumor location, size, and relationship to surrounding neurovascular structures
- Narrative description of tissue planes dissected and anatomical structures encountered or sacrificed during radical resection
- If modifier 22 is appended, operative note must explicitly document why the work was substantially greater than typical for this procedure
Applicable modifiers
Modifiers commonly billed with this code.
Source · AMA CPT modifier descriptors · CMS NCCI Policy Manual
What this code covers
Source · Editorial summary grounded in 6 cited references ↓
CPT 23078 covers radical resection of a malignant soft tissue tumor — typically a sarcoma — from the shoulder area when the tumor and its required surgical margins total 5 cm or more. This is not a simple excision: the resection extends well beyond the tumor borders into surrounding tissue and anatomical structures suspected of involvement, reflecting the oncologic intent of achieving clear margins. The 90-day global period means all routine postoperative care through day 90 is bundled. Any E/M visit or procedure unrelated to the tumor resection during that window requires modifier 24 or 79, respectively.
Site of service matters significantly here. The HOPD and ASC facility payments differ substantially (see the Site of Service comparison table). Surgeons operating in an ASC for a case of this magnitude should confirm the facility's implant and instrumentation policies before scheduling, as cost outliers can affect case profitability and site selection decisions.
For cases where the resection complexity is substantially greater than typical — extensive neurovascular involvement, prior radiation fields, or unusually difficult dissection planes — modifier 22 is appropriate, but the operative note must explicitly quantify the additional work. Vague references to 'difficult dissection' will not survive audit.
RVU & reimbursement
Component RVUs and Medicare national rate. Actual payment varies by GPCI locality.
Source · CMS Physician Fee Schedule, RVU26A · January 2026
| Work RVU | 21.99 |
| Practice expense RVU | 12.68 |
| Malpractice RVU | 5.02 |
| Total RVU | 39.69 |
| Medicare national rate | $1,325.68 |
| Global period | 90 days |
Payment by site of service
Medicare pays different rates by setting. HOPD typically pays substantially more than ASC for the same procedure.
Source · CMS OPPS Addendum B·ASC HCPCS payment rates·2026
| Setting | Medicare rate (national) |
|---|---|
Office (PFS non-facility) Procedure performed in physician's office | $1,325.68 |
HOPD (APC 5073) Hospital outpatient department | $2,967.63 |
ASC (PI G2) Ambulatory surgical center (freestanding) | $1,248.36 |
Common denial reasons
The recurring reasons claims for CPT 23078 get rejected.
Source · Editorial brief grounded in CMS NCCI edits, AAOS coding appeals, and cited references ↓
- Tumor size not documented to meet the 5 cm threshold — use 23077 if tumor plus margins are under 5 cm
- Missing or delayed pathology report at time of claim submission, leaving malignant diagnosis unsupported
- Modifier 22 appended without specific operative note language quantifying increased complexity or time
- Routine postoperative E/M visits billed without modifier 24 during the 90-day global period
- Laterality modifier (LT or RT) omitted, triggering payer edits requiring additional documentation before payment
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 6 cited references ↓
01What separates 23078 from 23077?
02Does 23078 require a malignant diagnosis to bill?
03Can I bill a separate E/M on the same day as 23078?
04How does the 90-day global period affect post-op billing?
05When is modifier 22 justified on 23078?
06Is bilateral resection of shoulder tumors realistic, and how is it billed?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CMS Physician Fee Schedule 2026
- 02cms.govhttps://www.cms.gov/files/document/03-chapter3-ncci-medicare-policy-manual-2026-final.pdf
- 03aapc.comhttps://www.aapc.com/codes/cpt-codes/23078
- 04findacode.comhttps://www.findacode.com/cpt/23078-cpt-code.html
- 05cgsmedicare.comhttps://www.cgsmedicare.com/medicare_dynamic/j15/partb/ptpb/ptp.aspx
- 06mdclarity.comhttps://www.mdclarity.com/cpt-code/23078
Mira AI Scribe
Mira's AI scribe captures tumor size, margins, anatomical structures resected, approach, and the surgeon's description of dissection complexity directly from dictation. It flags cases where the operative note doesn't explicitly confirm the 5 cm threshold or document why radical — rather than simple — resection was performed, the two most common triggers for medical necessity denials on this code.
See how Mira captures CPT 23078 documentation